Qisheng Biological Preparation

Shanghai Qisheng Biologic Preparation is a prominent Chinese biotechnology company that specializes in the development and production of medical biomaterials. Established in 1992 and currently operating as a subsidiary of Haohai Biological Technology, the company is a leader in the fields of ophthalmology, orthopedics, and surgical anti-adhesion. Its primary products include sodium hyaluronate injections for cataract surgery and osteoarthritis, as well as medical chitosan and absorbable hemostatic materials. The company maintains large-scale GMP-compliant manufacturing facilities and is recognized for its innovation in chitin-based medical applications. Qisheng's products are widely used in hospitals across China and are increasingly being exported to international markets.